STK11 and cancer: Patients with PJS have an increased risk of cancer and it is interesting to speculate that IL11-mediated activation of wildtype LKB1 [73], on top of the germline, PJS-causing LKB1 LOF mutation, plays a role in cancer risk in these patients.